- Home
- BSBR vs RVMD Comparison
BSBR vs RVMD Comparison
Compare BSBR & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSBR | RVMD |
|---|---|---|
| Founded | 1970 | 2014 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.6B | 40.3B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BSBR | RVMD |
|---|---|---|
| Price | $4.51 | $189.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 25 |
| Target Price | $6.77 | ★ $258.84 |
| AVG Volume (30 Days) | ★ 4.8M | 1.9M |
| Earning Date | 07-29-2026 | 11-04-2026 |
| Dividend Yield | ★ 6.28% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.56 | N/A |
| Revenue Next Year | $7.49 | $526.64 |
| P/E Ratio | $11.02 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.38 | $57.74 |
| 52 Week High | $7.32 | $224.31 |
Technical Indicators
Market Signals| Indicator | BSBR | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 26.31 | 47.33 |
| Support Level | N/A | $188.18 |
| Resistance Level | $5.58 | $194.19 |
| Average True Range (ATR) | 0.15 | 8.19 |
| MACD | -0.12 | 0.60 |
| Stochastic Oscillator | 9.26 | 50.51 |
Price Performance
Historical ComparisonAbout BSBR Banco Santander Brasil SA each representing one unit
Banco Santander (Brasil) SA is part of Santander Group, a Spanish bank. It operates across two segments; the Commercial Banking segment, catering to both individual and corporate client and the Global Wholesale Banking segment, which encompasses Investment Banking and Markets operations, including the Treasury and Equity Business Departments. The bank generates majority of its revenue from the Commercial Banking segment and has operations in Brazil and internationally.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.